Search
Close this search box.
Logo Asphalion

New European Project | NABIHEAL in biomaterials for complex wound healing

The meeting provided the opportunity to interact in person with all the consortium partners and establish the first collaborative activities to ensure timely delivery of the project milestones.

The meeting provided the opportunity to interact in person with all the consortium partners and establish the first collaborative activities to ensure timely delivery of the project milestones.
January 20, 2023

The Horizon Europe project NABIHEAL, was launched last week in Barcelona with the first meeting of the international consortium, formed by 14 partners from 7 countries, including research centers, universities, and private companies.

Our experts Marta Rayo Lunar, Oriol Penon and Sergio Vega attended the KoM. Asphalion is proud member of the consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting. In order to achieve this, Asphalion will:

  • Set up a Regulatory roadmap
  • Organize a regulatory workshop
  • Be in charge of early regulatory engagement
  • Outline of Clinical development
  • Continuously assessment of Regulatory

 

NABIHEAL stands for “Antimicrobial Nanostructured Biomaterials for Complex Wound Healing” and is funded under the Horizon Europe Research and Innovation programme, and it aims at solving two unmet medical needs in complex wound healing: on the one hand, affordable treatments for wound infections and prevention of complications during wound healing, and on the other, a strategy to optimize the composition and efficacy of wound dressings. The project will advance on the synthesis of advanced nanostructured biomaterials as an alternative to the commonly used silver-based materials.

For further information, have a look at the press release: Nabiheal Press Release

You can also contact us at: info@asphalion.com

This project received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101092269.

Search News & Events

  • Filter by category

Share

Related news and events

TUMOR-LN-oC | 36-month meeting

ASPHALION experts Enrique Gutierrez and Marta Morales have participated this week in the 36-month follow-up and review meeting of the Horizon project Tumor-LN-oC in Athens

CTIS applicable | Faster Access to Clinical Trial Information in Europe

CTIS is the single-entry point for the submission and assessment of clinical trial applications in the EU. It features a public, searchable database aimed at delivering a high level of transparency. The authorisation and oversight of clinical trials are managed by EU/EEA Member States, while the EMA maintains the CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

ARDAT | General Assembly

This week ARDAT project members met at the University of Sheffield to celebrate its general assembly. The ARDAT project aims to develop tools and provide

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting